Revenue Breakdown
Composition ()
No data
Revenue Streams
Intelligent Bio Solutions Inc (INBS) generates its revenue primarily from Commercially available Intelligent Fingerprinting Products , which accounts for 93.6% of total sales, equivalent to $789.64K. Understanding this concentration is critical for investors evaluating how INBS navigates market cycles within the Biotechnology & Medical Research industry.
Profitability & Margins
Evaluating the bottom line, Intelligent Bio Solutions Inc maintains a gross margin of 19.83%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -290.89%, while the net margin is -299.59%. These profitability ratios, combined with a Return on Equity (ROE) of -146.12%, provide a clear picture of how effectively INBS converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, INBS competes directly with industry leaders such as IVF and TNON. With a market capitalization of $7.22M, it holds a significant position in the sector. When comparing efficiency, INBS's gross margin of 19.83% stands against IVF's 28.04% and TNON's 65.90%. Such benchmarking helps identify whether Intelligent Bio Solutions Inc is trading at a premium or discount relative to its financial performance.
